|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
ALZN
|
Alzamend Neuro, Inc.
|
US
|
NASDAQ
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
CGTX
|
Cognition Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IGC
|
India Globalization Capital Inc.
|
US
|
AMEX
|
|
IKT
|
Inhibikase Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
KMPH
|
KemPharm, Inc.
|
US
|
NASDAQ
|
|
LFST
|
LifeStance Health Group, Inc.
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
|
NLSP
|
NLS Pharmaceutics Ltd.
|
US
|
NASDAQ
|
|
NVOS
|
Novo Integrated Sciences, Inc.
|
US
|
NASDAQ
|
|
NXL
|
Nexalin Technology, Inc.
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
RGC
|
Regencell Bioscience Holdings Limited
|
US
|
NASDAQ
|
|
RVPH
|
Reviva Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
US
|
NASDAQ
|
|
VLON
|
Vallon Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ACW
|
Actinogen Medical Ltd
|
AU
|
ASX
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|